Guardant Health Inc at Canaccord Genuity Growth Conference Transcript
We're pleased to have Guardant Health with us today. Guardant is about a $10 billion, $11 billion market cap leader in liquid biopsies. The company IPO-ed in October 2018 at around $19 a share. The stock today is over $100. It was the largest IPO in the history of my sector.
Guardant works with over 50 of the most important biopharma companies in the world and they've pioneered liquid biopsy comprehensive profiling with their market-leading Guardant360 panel. Helmy is the company's Co-Founder, President and CEO. And to my left, we have Derek Bertocci, the company's Chief Financial Officer. Guys, thank you very much.
Thank you for having us.
Questions & Answers
So I guess the first question for you, Helmy, since you cofounded the company, you and AmirAli developed a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
